RIM
BMY icon

Redpoint Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Redpoint Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.36M Sell
47,295
-8,446
-15% -$613K 0.49% 36
2022
Q2 		$4.29M Buy
55,741
+638
+1% +$48.6K 0.51% 38
2022
Q1 		$4.02M Sell
55,103
-723
-1% -$48.5K 0.4% 52
2021
Q4 		$3.48M Sell
55,826
-885
-2% -$51.9K 0.28% 87
2021
Q3 		$3.36M Sell
56,711
-2,722
-5% -$179K 0.29% 85
2021
Q2 		$3.97M Hold
59,433
– – 0.32% 73
2021
Q1 		$3.75M Buy
59,433
+305
+0.5% +$19K 0.32% 81
2020
Q4 		$3.67M Buy
59,128
+3,670
+7% +$226K 0.37% 66
2020
Q3 		$3.34M Sell
55,458
-77,356
-58% -$4.66M 0.36% 72
2020
Q2 		$7.81M Sell
132,814
-14,044
-10% -$840K 0.43% 56
2020
Q1 		$8.19M Sell
146,858
-9,153
-6% -$559K 0.51% 43
2019
Q4 		$10M Buy
156,011
+40,338
+35% +$2.31M 0.49% 41
2019
Q3 		$5.87M Buy
115,673
+820
+0.7% +$38.5K 0.31% 72
2019
Q2 		$5.21M Sell
114,853
-16,229
-12% -$756K 0.28% 84
2019
Q1 		$6.25M Buy
131,082
+1,789
+1% +$89.1K 0.31% 73
2018
Q4 		$6.72M Sell
129,293
-1,825
-1% -$98.1K 0.39% 56
2018
Q3 		$8.14M Sell
131,118
-3,007
-2% -$178K 0.41% 48
2018
Q2 		$7.42M Hold
134,125
– – 0.4% 55
2018
Q1 		$8.48M Sell
134,125
-5,833
-4% -$375K 0.47% 48
2017
Q4 		$8.58M Buy
+139,958
New +$8.75M 0.47% 46

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redpoint Investment Management's BMY Position: Q3 2022 in Review

Redpoint Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q3 2022, selling an estimated $613K and leaving 47,295 shares worth $3.36M. The position accounts for 0.49% of the portfolio, ranked #36.

Redpoint Investment Management first reported a position in BMY in Q4 2017 and has held it in 20 quarters since. The position peaked at $10M in Q4 2019. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Redpoint Investment Management held 47,295 shares of Bristol-Myers Squibb worth $3.36M as of Q3 2022.
  • Redpoint Investment Management sold 8,446 Bristol-Myers Squibb shares in Q3 2022, an estimated $613K.
  • Bristol-Myers Squibb made up 0.49% of Redpoint Investment Management's portfolio in Q3 2022, its #36 holding.
  • Redpoint Investment Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Bristol-Myers Squibb position peaked at $10M in Q4 2019.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.